Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 5 | Journal of Translational Medicine

Figure 5

From: Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies

Figure 5

Effect of lixisenatide treatment on apoptosis and contractility of isolated cardiomyocytes. (A) Caspase-3/7 activity is reduced in cardiomyocytes incubated with either insulin or lixisenatide (each at 100 nM). (B, C) Lixisenatide (Lixi) but not GLP-1 (6–36)-amide increases fractional shortening. Isoprenaline (Iso, 1nM) served as positive control. (D). Cardiomyocytes isolated from GLP-1 receptor knockout mice respond to lixisenatide. Mean values and SEM are given. In the fractional shortening experiments, n > 18 single cardiomyocytes were measured for each group.

Back to article page